21-42477439-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_080860.4(RSPH1):​c.579A>G​(p.Arg193Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0362 in 1,613,592 control chromosomes in the GnomAD database, including 1,251 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 92 hom., cov: 34)
Exomes 𝑓: 0.037 ( 1159 hom. )

Consequence

RSPH1
NM_080860.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.08
Variant links:
Genes affected
RSPH1 (HGNC:12371): (radial spoke head component 1) This gene encodes a male meiotic metaphase chromosome-associated acidic protein. This gene is expressed in tissues with motile cilia or flagella, including the trachea, lungs, airway brushings, and testes. Mutations in this gene result in primary ciliary dyskinesia-24. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 21-42477439-T-C is Benign according to our data. Variant chr21-42477439-T-C is described in ClinVar as [Benign]. Clinvar id is 227051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0296 (4515/152390) while in subpopulation NFE AF = 0.0415 (2822/68030). AF 95% confidence interval is 0.0402. There are 92 homozygotes in GnomAd4. There are 2265 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 92 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH1NM_080860.4 linkc.579A>G p.Arg193Arg synonymous_variant Exon 7 of 9 ENST00000291536.8 NP_543136.1 Q8WYR4-1
RSPH1NM_001286506.2 linkc.465A>G p.Arg155Arg synonymous_variant Exon 6 of 8 NP_001273435.1 Q8WYR4-2
RSPH1XM_011529786.2 linkc.507A>G p.Arg169Arg synonymous_variant Exon 6 of 8 XP_011528088.1
RSPH1XM_005261208.3 linkc.372A>G p.Arg124Arg synonymous_variant Exon 5 of 7 XP_005261265.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH1ENST00000291536.8 linkc.579A>G p.Arg193Arg synonymous_variant Exon 7 of 9 1 NM_080860.4 ENSP00000291536.3 Q8WYR4-1
RSPH1ENST00000398352.3 linkc.465A>G p.Arg155Arg synonymous_variant Exon 6 of 8 5 ENSP00000381395.3 Q8WYR4-2
RSPH1ENST00000493019.1 linkn.2197A>G non_coding_transcript_exon_variant Exon 6 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.0297
AC:
4520
AN:
152272
Hom.:
92
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00694
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0224
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0329
Gnomad FIN
AF:
0.0533
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0415
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0336
AC:
8435
AN:
251312
AF XY:
0.0356
show subpopulations
Gnomad AFR exome
AF:
0.00622
Gnomad AMR exome
AF:
0.0176
Gnomad ASJ exome
AF:
0.0613
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0501
Gnomad NFE exome
AF:
0.0397
Gnomad OTH exome
AF:
0.0365
GnomAD4 exome
AF:
0.0369
AC:
53934
AN:
1461202
Hom.:
1159
Cov.:
33
AF XY:
0.0375
AC XY:
27274
AN XY:
726916
show subpopulations
Gnomad4 AFR exome
AF:
0.00535
AC:
179
AN:
33474
Gnomad4 AMR exome
AF:
0.0187
AC:
836
AN:
44722
Gnomad4 ASJ exome
AF:
0.0615
AC:
1608
AN:
26128
Gnomad4 EAS exome
AF:
0.0000756
AC:
3
AN:
39700
Gnomad4 SAS exome
AF:
0.0411
AC:
3540
AN:
86232
Gnomad4 FIN exome
AF:
0.0483
AC:
2579
AN:
53352
Gnomad4 NFE exome
AF:
0.0385
AC:
42751
AN:
1111446
Gnomad4 Remaining exome
AF:
0.0366
AC:
2212
AN:
60382
Heterozygous variant carriers
0
2431
4863
7294
9726
12157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1532
3064
4596
6128
7660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0296
AC:
4515
AN:
152390
Hom.:
92
Cov.:
34
AF XY:
0.0304
AC XY:
2265
AN XY:
74524
show subpopulations
Gnomad4 AFR
AF:
0.00690
AC:
0.00689804
AN:
0.00689804
Gnomad4 AMR
AF:
0.0223
AC:
0.0223325
AN:
0.0223325
Gnomad4 ASJ
AF:
0.0608
AC:
0.0607719
AN:
0.0607719
Gnomad4 EAS
AF:
0.000578
AC:
0.00057759
AN:
0.00057759
Gnomad4 SAS
AF:
0.0327
AC:
0.0326987
AN:
0.0326987
Gnomad4 FIN
AF:
0.0533
AC:
0.0532957
AN:
0.0532957
Gnomad4 NFE
AF:
0.0415
AC:
0.0414817
AN:
0.0414817
Gnomad4 OTH
AF:
0.0336
AC:
0.0335539
AN:
0.0335539
Heterozygous variant carriers
0
235
471
706
942
1177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0378
Hom.:
58
Bravo
AF:
0.0261
Asia WGS
AF:
0.0160
AC:
54
AN:
3478
EpiCase
AF:
0.0405
EpiControl
AF:
0.0418

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg193Arg in exon 7 of RSPH1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 4.4% (376/8600) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs149478284). -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
7.0
DANN
Benign
0.73
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149478284; hg19: chr21-43897549; COSMIC: COSV52319309; API